Confident Investing Starts With TipRanks Premium

NEOK Bio

https://neokbio.com/Therapeutics

NEOK Bio, Inc. is a biotechnology company focused on the development of novel antibody drug conjugates (ADCs) that are designed to improve outcomes for cancer patients. NEOK is rapidly advancing bispecific ADCs which represent a cutting-edge advancement, leveraging bispecific antibodies that target two complimentary antigens, potentially improving safety while enhancing the efficacy of ADCs in a wider range of tumors.

Leadership & Board

Current Number of Employees: 6
Current LinkedIn Followers: 973

Latest Estimated Valuation

Estimated Valuation: ―
Total Amount Raised: $75M
Total Funding Rounds: 1
Latest Funding Amount: $75M
Latest Funding Round: Series A
Post-Money Valuation: ―

Employee Trend

NEOK Bio had 6 employees as of October 12, 2026. The number of employees increased by 0 (0.00%) week-over-week.

6Latest Employee Count

0(0.00%)Week-Over-Week Change

Social Trend

NEOK Bio had 973 followers as of October 12, 2026. The number of followers increased by 1 (0.10%) week-over-week.

973Latest Followers Count

1(0.10%)Week-Over-Week Change

Funding Round

Funding Date	Funding Round	Amount Raised	Post-Money Valuation
Nov 04, 2025	Series A	$75.00M	―

Investors

Investor Name	Funding Round
ABL Bio, Inc.	Series A

Similar Companies

A snapshot of private companies similar to NEOK Bio, helping you discover and navigate related company profiles.

AtaCor Medical Inc

Rockcliffe Labs

Beacon Therapeutics

Related News and Analysis

NEOK Bio Targets Increased Investor Engagement Through Fall Conference Participation

NEOK Bio Targets Increased Investor Engagement Through Fall Conference Participation

A LinkedIn post from NEOK Bio indicates the company plans to engage with investors and industry stakeholders at multiple healthcare and biotech conferences in fall 2026. The post lists appearances

25d ago

NEOK Bio CEO Discusses Bispecific ADC Strategy for Solid Tumor Oncology

NEOK Bio CEO Discusses Bispecific ADC Strategy for Solid Tumor Oncology

A LinkedIn post from NEOK Bio reports that CEO Mayank Gandhi recently appeared on the Bio Report Podcast to discuss antibody-drug conjugates in solid tumor treatment. The post indicates a

1M ago

NEOK Bio Emphasizes Clinical Trial Efficiency and Bispecific ADC Pipeline

NEOK Bio Emphasizes Clinical Trial Efficiency and Bispecific ADC Pipeline

A LinkedIn post from NEOK Bio highlights CEO Mayank Gandhi’s participation in a PharmaVoice article on key challenges facing biopharma leaders. According to the post, Gandhi emphasizes an opportunity to

2M ago

Mogul Raises $15.5 Million Series A to Scale AI-Driven Real Estate Platform

Mogul Raises $15.5 Million Series A to Scale AI-Driven Real Estate Platform

New updates have been reported about Mogul. Mogul has closed an oversubscribed $15.5 million Series A round led by Draper Associates, lifting its valuation to $126 million and bringing total

20m ago

Arch Lending Backs Community Bitcoin Reserve Model in Chicago’s Altgeld Gardens

Arch Lending Backs Community Bitcoin Reserve Model in Chicago’s Altgeld Gardens

New updates have been reported about Arch Lending. Arch Lending, the U.S.-based alternative-asset lending platform operated by ChainFi, Inc., has become a founding private-sector supporter of the Altgeld Bitcoin Reserve

2h ago

Lantern Launches Glo, an AI-Native Platform to Run Staffing Operations

Lantern Launches Glo, an AI-Native Platform to Run Staffing Operations

New updates have been reported about Lantern. Lantern has introduced Glo, an AI-native staffing and recruiting platform positioned as a full replacement for traditional applicant tracking and CRM systems, debuting

3h ago

Scanntech Secures $180 Million Series F to Accelerate Latin American Retail Data Expansion

Scanntech Secures $180 Million Series F to Accelerate Latin American Retail Data Expansion

New updates have been reported about Scanntech. Scanntech has raised $180 million in a Series F round led by L Catterton, with Partners Group co‑leading and Bradesco and SPX participating,

3h ago

Aatmunn Raises Up to $8 Million to Scale SPANR Industrial Intelligence Platform

Aatmunn Raises Up to $8 Million to Scale SPANR Industrial Intelligence Platform

New updates have been reported about Aatmunn. Aatmunn, the industrial intelligence company behind the SPANR platform, has secured up to $8 million in growth capital from Memento Growth Partners and

3h ago

Ursa Major Elevates Jason Meredith to President as It Scales and Eyes IPO

Ursa Major Elevates Jason Meredith to President as It Scales and Eyes IPO

New updates have been reported about Ursa Major. Ursa Major has promoted Jason Meredith to President, giving him end-to-end responsibility for business execution and full profit-and-loss oversight as the advanced

3h ago

Semperis Expands Global Cyberwar Documentary Tour to Key Industry Hubs

Semperis Expands Global Cyberwar Documentary Tour to Key Industry Hubs

New updates have been reported about Semperis. Semperis, a privately held identity-centric cyber resilience provider, is broadening the world tour of its feature-length cyberwar documentary, “Midnight in the War Room,”

4h ago